Jury Releases Accusations Over J&J Regarding Talc Cancer Lawsuit

Jury Releases Accusations Over J&J Regarding Talc Cancer Lawsuit

Headlines Health

According to the Reuters report; on Wednesday, the California judgment board in Humboldt County Superior Court, Eureka legally released Johnson & Johnson from the court hearing by declining the accusation by Carla Allen, a woman suffering from mesothelioma cancer, caused by the use of the talc-based company’s products adulterated with asbestos, stated by the company.

Regarding the claim by Allen, J&J responded with the contradiction saying that the talc products manufactured by the company have been passing the regulatory approvals and scientific testing from the decades, proving the products to be asbestos-free and safe for daily use.

Complainants in the lawsuit claimed that the company was familiar with their talc products containing asbestos fibers and the obscured risks related to it. The California jury arrived at its judgment after seven weeks long trials and hearings.

According to the regulatory filing for October and latest case filings in a federal court of New Jersey, the company is dealing with 11,700 cases related to talc, of which over 9,700 cases are associated with the plaintiffs’ allegations over ovarian cancer. However, the remaining cases involve claims related to the asbestos presence in J&J’s talc due to which plaintiffs developed mesothelioma.

Till now, J&J has been released legally from three mesothelioma cases. The company was sued by plaintiffs with $142 Million as per the New Jersey and California jury decisions. The company was hit by Missouri jury with a massive charge of $4.69 Billion by allegation over asbestos adulteration that has affected 22 women with ovarian cancer.

On Tuesday, a new case has been filed by Attorney General Gurbir Grewal against J&J’s subsidiary, Janssen Pharmaceuticals Inc. for provoking opioid catastrophe by misleading doctors and patients regarding their two opioid products. Janssen Pharmaceuticals is the first company in New Jersey against which opioid production suit has been filed.